Literature DB >> 31796160

Treatment of calcinosis associated with adult and juvenile dermatomyositis using topical sodium thiosulfate via fractionated CO2 laser treatment.

Misty G Eleryan1, Olabola Awosika2, Sophia Akhiyat3, Azam Qureshi2, Monica Rengifo-Pardo1, Rodolfo Curiel1, Lisa G Rider4, Alison Ehrlich5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31796160      PMCID： PMC7108296     

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  8 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

2.  Intravenous immunoglobulin therapy for dystrophic calcinosis cutis: unreliable in our hands.

Authors:  Andrew H Kalajian; Jennifer H Perryman; Jeffrey P Callen
Journal:  Arch Dermatol       Date:  2009-03

3.  Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.

Authors:  Bita Arabshahi; Robert A Silverman; Olcay Y Jones; Lisa G Rider
Journal:  J Pediatr       Date:  2012-01-13       Impact factor: 4.406

4.  Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis.

Authors:  Hideki Nakamura; Atsushi Kawakami; Hiroaki Ida; Eri Ejima; Tomoki Origuchi; Katsumi Eguchi
Journal:  J Rheumatol       Date:  2006-08       Impact factor: 4.666

Review 5.  Sodium thiosulfate: new hope for the treatment of calciphylaxis.

Authors:  Melvin R Hayden; David J A Goldsmith
Journal:  Semin Dial       Date:  2010 May-Jun       Impact factor: 3.455

6.  Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis.

Authors:  I Pagnini; G Simonini; T Giani; E Marrani; D Moretti; G Vannucci; L Cantarini; R Cimaz
Journal:  Clin Exp Rheumatol       Date:  2013-11-14       Impact factor: 4.473

Review 7.  Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).

Authors:  Lisa G Rider; Victoria P Werth; Adam M Huber; Helene Alexanderson; Anand Prahalad Rao; Nicolino Ruperto; Laura Herbelin; Richard Barohn; David Isenberg; Frederick W Miller
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

8.  Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate.

Authors:  Samy Slimani; Amina Abdessemed; Assia Haddouche; Aicha Ladjouze-Rezig
Journal:  Joint Bone Spine       Date:  2009-12-23       Impact factor: 4.929
  8 in total
  1 in total

Review 1.  Local, non-systemic, and minimally invasive therapies for calcinosis cutis: a systematic review.

Authors:  Joanna Nowaczyk; Michał Zawistowski; Piotr Fiedor
Journal:  Arch Dermatol Res       Date:  2021-06-24       Impact factor: 3.033
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.